IL6 and melanoma: The decreased level of these modifications in melanoma cells may be the reason for the lack of silencing of pro-inflammatory pathways [77], which is also evidenced by the increased level of pro-inflammatory cytokines (IL-6/12 and ANGPTL 3) compared to untreated cells.